An in Vivo Approach to Structure Activity Relationship Analysis of Peptide Ligands

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2007 Mar 23

PMID 17377744

Citations 14

Authors

Xiaomin Fan

Ruben Venegas

Robert Fey

Henri van der Heyde

Mark A Bernard

Elias Lazarides

Catherine M Woods

Affiliations

Soon will be listed here.

Abstract

Purpose: The goals in this study were several-fold. First, to optimize the in vivo phage display methodology by incorporating phage pharmacokinetic properties, to isolate peptides that target the brain microvasculature, and then to build focused libraries to obtain structure activity relationship information in vivo to identify the optimal targeting motif.

Materials And Methods: The blood pharmacokinetics of filamentous and T7 phage were evaluated to choose the optimal platform. A randomized peptide library with a motif CX(10)C was constructed in T7 phage and used for in vivo panning. Focused peptide libraries around each structural element of the brain-specific peptide were constructed to perform kinetic structure activity relationship (kSAR) analysis in vivo. To determine potential function, sepsis was induced in mice by LPS administration and four hours later the effect of GST-peptide on adhesion of rhodamine-labelled lymphocytes or CFDA-labelled platelets to pial microvasculature was observed by intravital microscopy.

Results: The blood phamacokinetics of T7 was rapid (half-life of 12 min) which aids the clearance of non-specific phage. In vivo panning in brain enriched for isolates expressing the motif CAGALCY. Kinetic analysis of focused libraries built around each structural element of the peptide provided for rapid pharmacophore mapping. The computer modeling data suggested the peptide showed similarities to peptide mimetics of adhesion molecule ligands. GST-CAGALCY but not GST control protein was able to inhibit the rolling and adhesion of labeled platelets to inflamed pial vasculature. GST-CAGALCY had no effect on lymphocyte adhesion.

Conclusions: Incorporating normal blood phamacokinetics of T7 phage into in vivo phage display improves the ability to recover targeting peptide motifs and allows effective lead optimization by kSAR. This approach led to the isolation of a brain-specific peptide, CAGALCY, which appears to function as an effective antagonist of platelet adhesion to activated pial microvasculature.

Citing Articles

Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges.

Parrasia S, Szabo I, Zoratti M, Biasutto L Mol Pharm. 2022; 19(11):3700-3729.

PMID: 36174227 PMC: 9644402. DOI: 10.1021/acs.molpharmaceut.2c00523.

Peptide Shuttles for Blood-Brain Barrier Drug Delivery.

Sanchez-Navarro M, Giralt E Pharmaceutics. 2022; 14(9).

PMID: 36145622 PMC: 9505527. DOI: 10.3390/pharmaceutics14091874.

Molecular ZIP codes in targeted drug delivery.

Ruoslahti E Proc Natl Acad Sci U S A. 2022; 119(28):e2200183119.

PMID: 35771944 PMC: 9282239. DOI: 10.1073/pnas.2200183119.

Vascular Endothelial Cells: Heterogeneity and Targeting Approaches.

Hennigs J, Matuszcak C, Trepel M, Korbelin J Cells. 2021; 10(10).

PMID: 34685692 PMC: 8534745. DOI: 10.3390/cells10102712.

In vivo phage display: identification of organ-specific peptides using deep sequencing and differential profiling across tissues.

Pleiko K, Posnograjeva K, Haugas M, Paiste P, Tobi A, Kurm K Nucleic Acids Res. 2021; 49(7):e38.

PMID: 33444445 PMC: 8053097. DOI: 10.1093/nar/gkaa1279.

References

Haubner R, Wester H, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman S . Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med. 2001; 42(2):326-36. View

Tute M . Principles and practice of Hansch analysis: a guide to structure-activity correlation for the medicinal chemist. Adv Drug Res. 1971; 6:1-77. View

Streeter P, Berg E, Rouse B, Bargatze R, Butcher E . A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature. 1988; 331(6151):41-6. DOI: 10.1038/331041a0. View

Salmi M, Jalkanen S . How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv Immunol. 1997; 64:139-218. DOI: 10.1016/s0065-2776(08)60889-5. View

Yip Y, Hawkins N, Smith G, Ward R . Biodistribution of filamentous phage-Fab in nude mice. J Immunol Methods. 1999; 225(1-2):171-8. DOI: 10.1016/s0022-1759(99)00044-7. View

Sircar I, Gudmundsson K, Martin R, Liang J, Nomura S, Jayakumar H . Synthesis and SAR of N-benzoyl-L-biphenylalanine derivatives: discovery of TR-14035, a dual alpha(4)beta(7)/alpha(4)beta(1) integrin antagonist. Bioorg Med Chem. 2002; 10(6):2051-66. DOI: 10.1016/s0968-0896(02)00021-4. View

Dubree N, Artis D, Castanedo G, Marsters J, Sutherlin D, Caris L . Selective alpha4beta7 integrin antagonists and their potential as antiinflammatory agents. J Med Chem. 2002; 45(16):3451-7. DOI: 10.1021/jm020033k. View

Nilsson F, Tarli L, Viti F, Neri D . The use of phage display for the development of tumour targeting agents. Adv Drug Deliv Rev. 2000; 43(2-3):165-96. DOI: 10.1016/s0169-409x(00)00068-5. View

George J, Sadler J, Lammle B . Platelets: thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2002; :315-34. DOI: 10.1182/asheducation-2002.1.315. View

10.

Ruoslahti E, Rajotte D . An address system in the vasculature of normal tissues and tumors. Annu Rev Immunol. 2000; 18:813-27. DOI: 10.1146/annurev.immunol.18.1.813. View

11.

Egbertson M, Chang C, Duggan M, Gould R, Halczenko W, Hartman G . Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp. J Med Chem. 1994; 37(16):2537-51. DOI: 10.1021/jm00042a007. View

12.

Butcher E, Picker L . Lymphocyte homing and homeostasis. Science. 1996; 272(5258):60-6. DOI: 10.1126/science.272.5258.60. View

13.

Huryn D, Konradi A, Ashwell S, Freedman S, Lombardo L, Pleiss M . The identification and optimization of orally efficacious, small molecule VLA-4 antagonists. Curr Top Med Chem. 2004; 4(14):1473-84. DOI: 10.2174/1568026043387467. View

14.

Kubes P, Ward P . Leukocyte recruitment and the acute inflammatory response. Brain Pathol. 2000; 10(1):127-35. PMC: 8098371. DOI: 10.1111/j.1750-3639.2000.tb00249.x. View

15.

Pasqualini R, Ruoslahti E . Organ targeting in vivo using phage display peptide libraries. Nature. 1996; 380(6572):364-6. DOI: 10.1038/380364a0. View

16.

Blackburn B, Lee A, Baier M, Kohl B, Olivero A, Matamoros R . From peptide to non-peptide. 3. Atropisomeric GPIIbIIIa antagonists containing the 3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione nucleus. J Med Chem. 1997; 40(5):717-29. DOI: 10.1021/jm960652r. View

17.

von Andrian U, Mackay C . T-cell function and migration. Two sides of the same coin. N Engl J Med. 2000; 343(14):1020-34. DOI: 10.1056/NEJM200010053431407. View

18.

Jackson D, Quan C, Artis D, Rawson T, Blackburn B, Struble M . Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agents. J Med Chem. 1997; 40(21):3359-68. DOI: 10.1021/jm970175s. View

19.

Gurrath M, Muller G, Kessler H, Aumailley M, Timpl R . Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides. Eur J Biochem. 1992; 210(3):911-21. DOI: 10.1111/j.1432-1033.1992.tb17495.x. View

20.

Seydel J . Sulfonamides, structure-activity relationship, and mode of action. Structural problems of the antibacterial action of 4-aminobenzoic acid (PABA) antagonists. J Pharm Sci. 1968; 57(9):1455-78. DOI: 10.1002/jps.2600570902. View